Literature DB >> 16047216

Endocrine manifestations of craniopharyngioma.

Isil Halac1, Donald Zimmerman.   

Abstract

RATIONALE: Due to the proximity of craniopharyngiomas to the hypothalamus and pituitary gland, most children and adolescents presenting with these tumors will exhibit significant endocrine dysfunction. After treatment, these impairments can become a major cause of morbidity and mortality.
METHODS: The postoperative course of children undergoing surgery for craniopharyngioma is reviewed.
CONCLUSION: Even if hormone levels seem to be adequate in the short term after treatment, deficiencies may develop over years and need to be monitored closely.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047216     DOI: 10.1007/s00381-005-1246-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  44 in total

Review 1.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

2.  Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience.

Authors:  T Moshang; A C Rundle; D A Graves; J Nickas; A Johanson; A Meadows
Journal:  J Pediatr       Date:  1996-05       Impact factor: 4.406

3.  Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis.

Authors:  J R Kerrigan; J D Veldhuis; S A Leyo; A Iranmanesh; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

4.  Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.

Authors:  J I Isojärvi; J Turkka; A J Pakarinen; M Kotila; J Rättyä; V V Myllylä
Journal:  Epilepsia       Date:  2001-07       Impact factor: 5.864

5.  Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma.

Authors:  M Hayashi; K Tomobe; K Hoshimoto; T Ohkura
Journal:  Int J Clin Pract       Date:  2002-03       Impact factor: 2.503

6.  Risk factors for the development of obesity in children surviving brain tumors.

Authors:  Robert H Lustig; Susan R Post; Kleebsabai Srivannaboon; Susan R Rose; Robert K Danish; George A Burghen; Xiaoping Xiong; Shengjie Wu; Thomas E Merchant
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

7.  Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.

Authors:  K R Lyen; D B Grant
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

8.  Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.

Authors:  E J Schoenle; J Zapf; A Prader; T Torresani; E A Werder; M Zachmann
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

9.  Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients.

Authors:  M J Thomsett; F A Conte; S L Kaplan; M M Grumbach
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

10.  Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment.

Authors:  G Abbaticchio; F M Micale; V A Giagulli; R Giorgino
Journal:  Arch Androl       Date:  1985
View more
  14 in total

Review 1.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 2.  Current best practice in the management of patients after pituitary surgery.

Authors:  Alessandro Prete; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Ther Adv Endocrinol Metab       Date:  2017-03-01       Impact factor: 3.565

Review 3.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

4.  Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician.

Authors:  Maria A Kalina; Eliza Skala-Zamorowska; Barbara Kalina-Faska; Ewa Malecka-Tendera; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2009-06-17       Impact factor: 1.475

5.  Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children.

Authors:  Mohammad Maarouf; Faycal El Majdoub; Manuel Fuetsch; Mauritius Hoevels; Ralph Lehrke; Frank Berthold; Jürgen Voges; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2015-11-05       Impact factor: 3.621

6.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

Review 7.  Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients.

Authors:  Anna M M Daubenbüchel; Hermann L Müller
Journal:  J Clin Med       Date:  2015-03-09       Impact factor: 4.241

8.  Suprasellar mature cystic teratoma: an unusual location for an uncommon tumor.

Authors:  Raed B Sweiss; Faris Shweikeh; Fadi B Sweiss; Stephanie Zyck; Lauren Dalvin; Javed Siddiqi
Journal:  Case Rep Neurol Med       Date:  2013-10-02

9.  Choice of fluid therapy in patients of craniopharyngioma in the perioperative period: A hospital-based preliminary study.

Authors:  K K Mukherjee; Pinaki Dutta; Apinderpreet Singh; Prakamya Gupta; Anand Srinivasan; Hemant Bhagat; S N Mathuriya; Viral N Shah; Anil Bhansali
Journal:  Surg Neurol Int       Date:  2014-07-08

10.  A Craniopharyngioma Associated With Elevated Cerebrospinal Fluid HCG Concentrations Misdiagnosed as a Germinoma.

Authors:  Weijun Gu; Weizhong Gu; Yulin Gu; Jie Li; Guoqing Yang; Qinghua Guo; Li Zang; Jin Du; Yu Pei; Jianming Ba; Zhaohui Lv; Jingtao Dou; Yiming Mu
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.